HD-OPM Archive
Topics › Aging & longevity

Targeting senescent-cell inflammation (senomorphics) may beat killing the cells

Louis Nervegna · Jul 31, 2026 · ♥ 9 reactions · 0 comments · original Facebook post
Aging & longevityInflammation & CRP
AI summary & key facts

Louis says senescent cells cause multiple diseases including CVD and argues that shutting off their inflammation may be better than senolytics. Mayo researchers found a mitochondrial pathway driving this inflammation.

Accumulation of senescent cells with advancing age plays a direct causal role in multiple diseases, including CVD.

Instead of killing senescent cells (with drugs called senolytics), a better strategy may be shutting off the inflammation-generating pathways that make these cells dangerous in the first place (with drugs called senomorphics).

#senescenceHD #senolyticsHD #mayoclinicHD #agingHD #longevityHD #senomorphicsHD #saspHD

Shared from Mayo Clinic · original post

Can we reduce harmful inflammation from aging cells without destroying the cells themselves?

Researchers have identified a new mitochondrial pathway that helps drive the chronic inflammation associated with aging. The findings could help pave the way for new therapies to combat age-related diseases driven by chronic inflammation.

Learn more:

newsnetwork.mayoclinic.orgScientists identify new mitochondrial pathway linked to harmful inflammation in agingmayocl.inNo photo description available.
← newer: Midlife vitamin D linked to later tau burden in Framingham polder: Fiber is linked to lower heart disease, dementia and cancer →